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What is the best approach 
to a solitary pulmonary nodule 
identiﬁ ed by chest x-ray?
Your initial risk assessment should include 
the patient’s smoking history, advancing 
age, cancer history, and chest radiography 
features (strength of recommendation 
[SOR]: A, based on a validated clinical 
decision rule). You’ll also need to review 
old chest radiographs (SOR: C, based on 
expert opinion). A solitary pulmonary nodule 
unchanged for >2 years on chest radiograph 
or containing benign central calcifi cations 
requires no further work-up (SOR: B, based 
on historical cohort studies). 
 While radiologists’ interpretations of a 
nodule’s calcifi cation on chest radiograph 
and malignancy on computed tomography 
(CT) are incorrect in a substantial portion 
of cases (SOR: B, based on limited-quality 
diagnostic cohort studies), spiral CT 
with contrast is still diagnostically useful 
in making decisions regarding watchful 
waiting, needle biopsy, or surgery (SOR: B, 
based on a decision analysis study). 
 18-fl uorodeoxyglucose positron 
emission tomography (FDG PET) is useful 
for assessing malignancy risk (SOR: B, 
based on decision analysis study), but not 
for solitary pulmonary nodules <1 cm (SOR: 
C, based on expert opinion). 
Direct more costly, invasive tests 
to those with higher risk of malignancy
Risk stratifi cation of a solitary pulmonary 
nodule allows the clinician to direct more 
costly and invasive testing to patients with a 
higher probability of malignancy. Historical 
factors such as previous cancer, advanced 
age, and smoking increase suspicion for 
malignancy, but CT is generally warranted 
in all new solitary pulmonary nodules 
found on chest radiographs. It’s important 
to obtain a thorough history regarding 
symptoms (cough, night sweats, weight 
loss), occupational exposure (asbestos, 
bird droppings, decaying wood), travel, 
and comorbid conditions (especially 
immunocompromised states); this is likely to 
prove helpful in the workup.
Parul Harsora, MD and Rhesa Sanni-Thomas, DO
UT Southwestern Medical Center, Dallas, Tex
Evidence-based answer
Clinical commentary
❚ Evidence summary
A solitary pulmonary nodule, or “coin le-
sion,” is an intraparenchymal fi nding on 
chest radiograph or CT that is less than 
3 to 4 cm in diameter and not associated 
with atelectasis or adenopathy. Malig-
nancy rates range from 15% to 75%, 
depending on the population studied.1 
Although early detection of malignancy 
portends a major improvement in surviv-
al (up to 75% at 5 years following sur-
gical resection of stage IA disease), most 
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lung cancers progress asymptomatically 
until quite advanced.2
The presumed benign nature of lesions 
that are either unchanged over 2 years 
or have central calcifi cations is based on 
3 retrospective studies from the 1950s.3–6 
However, these should not be considered 
absolutes. A recent study revisiting the 
original data calculated the predictive val-
ue of benign nature based on no growth 
to be only 65% (95% confi dence interval 
[CI], 47%–83%).7 Also, a study assessing 
the accuracy of radiologists’ assessment of 
calcifi cation in solitary pulmonary nod-
ules compared with thin-section CT found 
that 7% of “defi nitely calcifi ed” nodules 
on chest radiograph lacked calcifi cation 
on thin-section CT.8 
Which clinical variables 
best predict malignancy?
The best available clinical decision rule 
was derived and validated from a single 
split population of patients with solitary 
pulmonary nodules.9 The outcome vari-
able was defi ned as malignancy based 
on histologic tissue analysis or benignity 
by radiographic stability or resolution 
over 2 years. The authors did not report 
whether those determining outcomes and 
predictors were appropriately blinded. 
The authors found that 3 clinical 
variables (age, smoking history, and can-
cer history) plus 3 radiographic variables 
(diameter, spiculation, and nodule loca-
tion in the upper lobes) were independent 
predictors of malignancy. An online cal-
culator using this prediction model is 
available at www.chestx-ray.com/SPN/
SPNProb.html.10
CT or PET?
Three comparative studies observed 8 to 
12 radiologists’ readings of high-resolu-
tion CT images of 28 to 56 patients with 
solitary pulmonary nodules (established 
diagnoses by either histology or stability 
over time).11–13 Approximately half the 
nodules represented malignant lesions. 
Radiologists assigned a level of confi -
dence to their assessment of each case as 
benign or malignant. At a minimum, they 
were informed of each patient’s age and 
gender, and in 2 studies they also knew 
other information, such as the patient’s 
smoking and cancer histories. The study 
showed that the radiologists would have 
correctly diagnosed a pair of solitary 
pulmonary nodule cases, one malignant 
and one benign, between 75% and 83% 
of the time. Conversely, 17% to 25% of 
the time they would have diagnosed the 
case pair incorrectly.
A meta-analysis of 40 studies of FDG 
PET scanning for solitary pulmonary nod-
ules yielded a maximum joint sensitivity 
and specifi city of 90% (95% CI, 86.4%–
92.7%).14 The methodological quality of 
studies included in the meta-analysis was 
fair, with small sample sizes (inclusion cri-
teria were for a minimum of 10 patients 
with pulmonary nodules and malignant 
prevalence of at least 0.5); masking was 
frequently incomplete.
Sensitivity of histologic/cytologic 
tests varies
A recent systematic review of studies 
evaluating patients with suspected lung 
cancer looked into the diagnostic sensi-
tivity of various methods of histologic 
and cytologic tests.15 Researchers com-
pared the evaluated test results to a ref-
erence standard of pathology/histology, 
defi nitive cytology, or at least 1-year ra-
diographic follow-up. 
Transbronchial needle aspiration 
showed a sensitivity of 67% (95% CI, 
64%–70%) for peripheral lung malignan-
cy of any size; however, only 5 studies met 
study criteria and their sample sizes var-
ied greatly (n=20 to n=480). Eight studies 
looking at bronchoscopy (including brush 
or biopsy) for peripheral lung lesions 
<2 cm in diameter yielded a sensitivity of 
only 33% (95% CI, 28%–38%). In the 
same systematic review, 61 studies of trans-
thoracic needle aspiration for local-
ized pulmonary lesions of any size had 
a pooled sensitivity of 90% (95% CI, 
88%–92%). The prevalence of ma-
lignancy in the studies ranged from 
CT is cost-
effective when 
the probability 
of malignancy 
is less than 90%
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0.58 to 0.93.15 Factors affecting heteroge-
neity between studies included the wide 
range in study dates, imaging technology 
used, and study sizes.
What test is most cost-effective?
CT appears cost-effective when the pre-
test probability of malignancy is <90%; 
therefore, consider it on virtually all new 
cases of solitary pulmonary nodules.1 
Also, when CT and pretest risk-assess-
ments are discordant (eg, a patient has a 
low pretest probability of malignancy but 
his CT is suggestive of malignancy), the 
FDG PET scan is the most economically 
feasible at less than $20,000 per quality-
adjusted life year. 
Recommendations from others
The American College of Chest Physi-
cians (ACCP)2 suggests pursuing no fur-
ther evaluation if a nodule is unchanged 
for >2 years or has benign central calci-
fi cations. They recommend that physi-
cians perform CT on every patient with 
a new nodule to characterize the nodule, 
its location, and the mediastinum. They 
do not recommend PET scans for nod-
ules <1 cm. Patients who are marginal 
surgical candidates and have a negative 
PET scan should have a repeat CT scan 
in 3 months; serial CTs at 3, 6, 12, and 24 
months are suggested, too, if prior chest 
radiographs are negative.
The ACCP states that transthorac-
ic needle aspiration is not indicated in 
surgical candidates unless they decline 
surgery; then transthoracic needle aspi-
ration or a transbronchial approach are 
the preferred procedure. Transthoracic 
needle aspiration may also be useful in 
establishing a diagnosis for patients who 
are not surgical candidates or who have 
a high surgical risk.  
ACCP expert consensus favors the 
reference standard of video-assisted tho-
racoscopic surgery with wedge resection 
as the ideal method for obtaining tissue 
diagnosis in consenting, operable patients 
with solitary pulmonary nodules. Ob-
jective evidence is lacking on follow-up 
monitoring methods for patients with a 
nodule who do not have a tissue diagno-
sis and observation alone is chosen. ACCP 
expert consensus favors a 2-year follow-
up with CT scanning at 3, 6, 12, and 24 
months to monitor for nodule growth.2  ■
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